Could EU's New HTA Proposal Promote EU-Wide Reimbursement Of Personalized Medicine?
Personalized medicine has yet to really take off in the EU. One of the main barriers are the fragmented rules around reimbursement. Could the European Commission's health technology assessment proposal help?
You may also be interested in...
There are changes afoot in the regulation and reimbursement policy for IVDs in the EU and US. When it comes to personalized medicine, and companion diagnostics in particular, are the two markets becoming more polarized? Medtech Insight asked US- and EU-based attorneys at Hogan Lovells.
The European Commission's landmark proposal on health technology assessment regulation is meeting with a growing force of opposition. MedTech Europe’s Yves Verboven believes there are better solutions.
The EU Council is scheduled to debate the European Commission's EU-wide health technology assessment proposal today, but opposition to the concept within medtech circles has started to mount, notably in Germany.